VRSK AI Stock Analysis – Buy, Hold, or Avoid?
Verisk Analytics, Inc. (VRSK)
Verisk (VRSK) stands out as a high-quality, fundamentally strong analytics company with robust recurring revenues, premium margins, and a dominant market position. While the valuation is rich and technicals are mixed in the short term, positive sentiment, steady growth, and strong capital returns make it an attractive long-term investment, with moderate, manageable risks.
Fundamentals
Verisk (VRSK) exhibits strong and consistent financial performance, characterized by steady revenue growth, expanding margins, and robust earnings quality. The business model, focused on critical data analytics for the insurance and risk management industries, underpins a defensible competitive position. While valuation is rich, reflecting its premium metrics, the company's fundamentals justify optimism over a long-term horizon.
Financial Highlights
- Revenue
- Net Income
- Net Margin (%)
Revenue
5.87% YoY
Q4 2025
Net Income
-6.23% YoY
Q4 2025
Net Margin
Q4 2025
Growth Metrics
Revenue Growth YoY
Latest Quarter: Q4 2025
Net Income Growth YoY
Latest Quarter: Q4 2025
Revenue Per Share Growth YoY
Latest Quarter: Q4 2025
EPS Growth YoY
Latest Quarter: Q4 2025
Book Value Per Share Growth YoY
Latest Quarter: Q4 2025
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 778.8M | 768.3M | 772.6M | 753.0M | 735.6M | 725.3M | 716.8M | 704.0M |
| Revenue Growth YoY | +5.87% | +5.93% | +7.78% | +6.96% | +8.62% | +7.04% | +6.19% | +8.04% |
| Net Income | 197.2M | 225.5M | 253.3M | 232.3M | 210.3M | 220.0M | 307.8M | 219.6M |
| Net Income Growth YoY | -6.23% | +2.50% | -17.71% | +5.78% | +21.00% | +17.40% | +56.32% | +290.05% |
| EPS | $1.42 | $1.62 | $1.81 | $1.66 | $1.50 | $1.55 | $2.16 | $1.53 |
| EPS Growth YoY | -5.33% | +4.52% | -16.20% | +8.50% | +24.81% | +20.16% | +58.82% | +313.51% |
Profitability Metrics
Technical Analysis
VRSK is currently trading near $215, showing mixed technical signals with recent short-term bullish momentum but longer-term bearish moving averages. Key technical indicators suggest a cautious stance with momentum showing potential early strength but resistance near $213 is critical to overcome for sustained upside.
No extreme reading
Mixed signals
Strong trend active
Watching for cross
Key Technical Values
Price with Moving Averages
50-day, 150-day and 200-day simple moving averages
Relative Strength Index
Momentum oscillator measuring speed and magnitude of price changes
RSI (14)
Earnings
Verisk (VRSK) exhibits strong and consistent financial performance, characterized by steady revenue growth, expanding margins, and robust earnings quality. The business model, focused on critical data analytics for the insurance and risk management industries, underpins a defensible competitive position. While valuation is rich, reflecting its premium metrics, the company's fundamentals justify optimism over a long-term horizon.
Latest Earnings
Q4 2025 Earnings (Dec 31, 2025)
Earnings Per Share (EPS)
Actual
$1.82
Estimated
$1.61
Surprise
+$0.21
Surprise %
+13.04%
Revenue
Actual
$778.8M
Estimated
$773.57M
Surprise
+$5.23M
Surprise %
+0.68%
Historical Earnings
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | |
|---|---|---|---|---|---|---|---|---|
| Earnings Per Share | ||||||||
| EPS (Actual) | $1.82 | $1.72 | $1.88 | $1.73 | $1.61 | $1.67 | $1.74 | $1.63 |
| EPS (Estimated) | $1.61 | $1.70 | $1.78 | $1.68 | $1.60 | $1.60 | $1.64 | $1.53 |
| EPS Surprise | +$0.21 | +$0.02 | +$0.10 | +$0.05 | +$0.01 | +$0.07 | +$0.10 | +$0.10 |
| % Diff | +13.0% | +1.2% | +5.6% | +3.0% | +0.6% | +4.4% | +6.1% | +6.5% |
| Revenue | ||||||||
| Revenue (Actual) | $778.8M | $768.3M | $772.6M | $753M | $735.6M | $725.3M | $716.8M | $704M |
| Revenue (Estimated) | $773.57M | $776.25M | $768.73M | $749.82M | $733.7M | $722.19M | $722.45M | $699.07M |
| Revenue Surprise | +$5.23M | -$7.95M | +$3.87M | +$3.18M | +$1.9M | +$3.11M | -$5.65M | +$4.93M |
| % Diff | +0.7% | -1.0% | +0.5% | +0.4% | +0.3% | +0.4% | -0.8% | +0.7% |
Valuation
Verisk Analytics (VRSK) currently trades at a valuation that reflects a mature, high-margin analytics company with strong profitability and moderate growth. While some metrics indicate a premium relative to general market levels, its multiples have recently declined toward sector averages, supported by solid operational efficiency and robust return on equity. Analyst sentiment is generally positive with price targets suggesting moderate upside potential from current levels.
Valuation Metrics
Price to Earnings
TTM
Price to Sales
TTM
Price to Book
TTM
Enterprise Value to EBITDA
TTM
Enterprise Value to Revenue
TTM
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | |
|---|---|---|---|---|---|---|---|---|
| Price to Earnings | 39.43 | 38.90 | 42.99 | 44.94 | 46.11 | 43.17 | 31.08 | 37.97 |
| Price to Sales | 39.94 | 45.67 | 56.37 | 55.45 | 52.73 | 52.38 | 53.38 | 47.38 |
| Price to Book | 100.66 | 93.15 | 139.73 | 339.47 | 387.52 | 126.81 | 88.92 | 118.20 |
| Enterprise Value to EBITDA | 81.17 | 92.75 | 104.00 | 107.18 | 108.15 | 103.58 | 81.95 | 95.01 |
| Enterprise Value to Revenue | 43.61 | 49.29 | 60.00 | 59.20 | 56.75 | 56.24 | 57.08 | 51.29 |
Sentiment & Analyst Ratings
The market sentiment around Verisk Analytics (VRSK) is broadly positive, underpinned by strong Q4 2025 earnings, an aggressive share repurchase program, and dividend increases. Analyst opinions skew bullish with upgrades and raised price targets, although some caution exists regarding growth and valuation. Retail investors show optimism with increasing social buzz and notable price gains, reflecting confidence in the company’s capital return strategies.
Analyst Recommendations
Risk Assessment
Verisk Analytics (VRSK) exhibits moderate financial health with manageable liquidity and high leverage indicated by its debt metrics. The company faces notable industry-specific and operational risks such as pricing pressures, regulatory exposure, and cybersecurity threats; however, analyst sentiment remains cautiously optimistic with supportive earnings growth expectations and a positive view on long-term prospects.
Liquidity & Solvency
Current Ratio
Latest Quarter: Q4 2025
Quick Ratio
Latest Quarter: Q4 2025
Debt-to-Equity
Latest Quarter: Q4 2025
Debt-to-Assets
Latest Quarter: Q4 2025
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | |
|---|---|---|---|---|---|---|---|---|
| Liquidity Metrics | ||||||||
| Current Ratio | 1.20 | 1.19 | 1.53 | 1.27 | 0.74 | 0.82 | 0.95 | 1.09 |
| Quick Ratio | 1.20 | 1.19 | 1.53 | 1.27 | 0.74 | 0.82 | 0.95 | 1.09 |
| Solvency Metrics | ||||||||
| Debt-to-Equity | 16.30 | 12.98 | 11.00 | 31.99 | 32.43 | 10.88 | 7.64 | 10.99 |
| Debt-to-Assets | 0.81 | 0.78 | 0.71 | 0.77 | 0.76 | 0.71 | 0.69 | 0.69 |
Liquidity Assessment
Current Ratio: 1.20(Adequate)
Quick Ratio: 1.20(Strong)
The company has adequate liquidity but may face challenges in a downturn.
Solvency Assessment
Debt-to-Equity: 16.30(High)
Debt-to-Assets: 0.81(High)
The company has relatively high debt levels, which may increase financial risk in economic downturns.
Frequently Asked Questions about VRSK
AI Answers: Common Questions About VRSK
Get AI-powered answers to the questions investors ask most about Verisk Analytics, Inc.
Verisk is a good buy for long-term investors given its strong fundamentals, premium but fair valuation (P/E 33.19, EV/EBITDA ~20x), and positive sentiment. The current price around $215 is below analyst average targets ($237) and well below the 52-week high ($322.92), offering a reasonable entry for those with a multi-year horizon.
Unless your thesis has changed or you need liquidity, there is little reason to sell now; fundamentals are intact, sentiment is improving, and technicals do not signal a breakdown. Short-term traders may hold or trim if resistance at $213 fails, but long-term holders should stay the course.
The biggest risks are high leverage (debt-to-equity >16, debt >80% of assets), regulatory changes affecting data use, and technology disruption from AI competitors. While liquidity is adequate (current ratio ~1.2), a downturn or regulatory shift could pressure cash flows and valuation.
Analyst targets average $236.93, with some as high as $260; technical resistance is at $213, with support at $202 and downside risk to $185-$170 if market conditions worsen. Upside is moderate but realistic if growth and capital returns persist.
The stock trades at a premium (P/E 33.19, P/S ~10x, EV/EBITDA ~20x), but this is justified by high margins (gross >67%, operating >44%) and recurring revenues. Valuation has compressed from historical highs and is now fair relative to peers like Moody's and Equifax.
Fundamentals are strong: revenue grew 6.6% YoY to $3.07B, margins are robust (net margin ~29.6%), and earnings quality is high due to recurring revenues and strong cash flow. The business model is defensible, though leverage is elevated.
Technically, VRSK is below key moving averages (50/100/200-day), with RSI at 30.74 (neutral) and resistance at $213. Momentum is improving but not confirmed; traders should wait for a breakout above resistance with volume before entering.
Key catalysts include upcoming earnings reports, continued execution of the $2.5B share buyback, dividend increases, and any regulatory or macro developments affecting insurance analytics demand. Analyst upgrades and positive sentiment could also drive near-term price action.
Want a Personalized Answer?
Get AI-powered insights tailored to your risk tolerance and investment goals.